SOURCE: Vivakor, Inc.

January 13, 2014 12:53 ET

Vivakor Announces Acquisition of Its VivaCeuticals Division Which Will Merge With WellMed Global

HENDERSON, NV--(Marketwired - January 13, 2014) - VivaCeuticals Inc, a Division of Vivakor Inc. (PINKSHEETS: VIVK), announces merger with WellMed Global with the intent to file an S1 registration statement this year with the new entity. Regeneca Worldwide, a division of VivaCeuticals, is a direct response network marketing company markets and sells consumer goods that have a Whole Earth Whole Body approach to health via infomercials and direct selling. WellMed Global Inc. is a consumer goods company distributing products containing proprietary Tissue Growth Factors -- TGFs is a growing company with expansive opportunity. The combination of these companies' products, with the media exposure created from infomercials and advertisements, creates a powerful product focused distribution channel that will expand worldwide over the next three years. The new entity, Odyssey Group International Inc., will commence the audit and filing process early this year and plan on a S1 filing in the coming quarters. Additionally, Odyssey Group International Inc. plans on a dual filing in 2015 in Asia as it expands its sells channels to Asia, which is the largest direct selling channel for its products.

About Vivakor, Inc.

Vivakor, Inc, is a asset acquisition company that develops and acquires assets that generate revenue currently or in the near term. The Company acquires technologies and assets in the fields of precious minerals, biotechnology, and alternative energy. We have several mineral assets that have great value and both create a cash flow and a long term revenue stream for the Company. We have effectively acquired positions in other Green Energy companies. We have several operating assets that produce revenues and cash flow to the company. Our business model is to acquire cash-flowing or near term cash-flowing mineral and or technology assets that an identified need or a substantial market opportunity with a significant market. For more information please visit www.vivakor.com.

About Regence Worldwide, a division VivaCeuticals Inc.

Regeneca Worldwide is a recently acquired brand of products and business opportunity of Vivceuticals Inc. Regeneca Worldwide's philosophy and products are designed with this in mind. We aim to connect individual with individual, reconnecting them to the Earth's source of healing properties, and to do it with a symbiotic approach. Regeneca Worldwide specializes in direct response marketing. We drive customer acquisition, alongside direct sales networking. With our direct response network, we've created a revolutionary approach to home business ownership. Through television, radio, online, and print advertising, we can help to brand and commercialize your business, while developing a customer base and sales organization stretching across the globe. Regeneca Worldwide's products are unique, just like you. Working together, we can build and grow your home-based business to its full potential helping to "regenerate the quality of your life and your customer's lives." For more information please visit www.regeneca.com.

About WellMed Global Inc.

Well-Med Global, LLC was established to identify and offer scientifically proven products and services that are unique for the Health and Beauty Marketplaces. Products are based on breakthrough science and technology and have the potential to be the leaders in the global marketplace. Each product is carefully scrutinized for the benefits and enhanced properties to make it the best available product in efficacy and value. Currently, the main product focus is topical skin care collections using medical grade products and services that are based on stem cell and Growth Factor (GF) biotechnology. These products are manufactured in an FDA approved facility. WELL-MED Global products are manufactured exclusively in the United States meeting established product specifications. Growth Factors can now be produced in a laboratory for topical use. In multiple clinical studies, topically applied GF has been shown to reduce the signs of skin aging, including statistically significant reductions in fine lines and wrinkles and increases in dermal collagen synthesis. GF-technology has also been used successfully for encouraging healthy hair growth, reducing the appearance of scars, supporting the skin during post-procedure healing, and shortening the healing time. Well-Med Global currently has multiple product lines in the pipeline being tested and plan to introduce additional products as well as expanding into overall wellness products.

FORWARD-LOOKING STATEMENTS

This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.

Contact Information